Macrobid (nitrofurantoin) is generally safe to take while breastfeeding, as long as your baby is healthy and at least one month old. The drug does pass into breast milk, but in very small amounts: studies show that only about 0.05% to 0.28% of a maternal dose is recovered in breast milk within six hours. For most nursing infants, this trace exposure poses no meaningful risk.
There are, however, specific situations where Macrobid is not recommended during breastfeeding. Understanding those exceptions is important before filling your prescription.
How Much Reaches Your Baby
Nitrofurantoin concentrations in breast milk are higher than in blood plasma, with a milk-to-plasma ratio of roughly 2:1. That sounds alarming, but context matters. The drug’s overall concentration in your body is low to begin with, so even a 2:1 ratio translates to a tiny absolute amount. The total quantity an infant would ingest through a full day of nursing is a fraction of a percent of what you took.
At these levels, side effects in breastfed infants are uncommon. The NHS notes that nitrofurantoin “passes into breast milk in small amounts and is unlikely to cause side effects in your baby.”
When Macrobid Is Not Safe
There are two clear situations where Macrobid should be avoided during breastfeeding:
- Your baby is under one month old. Nitrofurantoin is not recommended for newborns younger than one month. Their immature systems are more vulnerable to the drug’s effects on red blood cells. The American Academy of Family Physicians advises against using nitrofurantoin while breastfeeding during the first month of life.
- Your baby has or may have G6PD deficiency. G6PD deficiency is an inherited condition that makes red blood cells more fragile. Even trace amounts of nitrofurantoin in breast milk can trigger hemolytic anemia, a dangerous breakdown of red blood cells, in affected infants. If your baby hasn’t been screened, or if G6PD deficiency runs in your family, this is worth discussing before starting the medication.
G6PD deficiency is more common in people of African, Mediterranean, Middle Eastern, and Southeast Asian descent. Most newborn screening programs in the U.S. do not universally test for it, though some states do. If you’re unsure of your baby’s status, ask your pediatrician.
What to Watch For in Your Baby
Even when Macrobid is considered safe, it’s worth keeping an eye on your baby during your course of treatment. Signs that could indicate a problem include unusual fussiness, poor feeding, pale or yellowing skin, or dark-colored urine. These could point to red blood cell breakdown and would warrant prompt medical attention. Most breastfed infants show no symptoms at all, but knowing what to look for gives you peace of mind.
Timing Your Dose Around Feedings
You might wonder whether taking Macrobid right after a feeding would reduce your baby’s exposure. There’s no formal guidance recommending this strategy for nitrofurantoin specifically. Because the drug is typically taken multiple times a day (every 12 hours for Macrobid), maintaining consistent spacing around feedings isn’t practical for most people. Given how little of the drug reaches breast milk in the first place, strategic timing is unlikely to make a clinically meaningful difference.
Alternative UTI Antibiotics While Breastfeeding
If Macrobid isn’t the right fit, whether because of your baby’s age, G6PD concerns, or side effects you’re experiencing, several other antibiotics treat UTIs effectively and are considered compatible with breastfeeding. The American Academy of Pediatrics lists trimethoprim-sulfamethoxazole and certain fluoroquinolones as options. Trimethoprim-sulfamethoxazole carries a similar caution: it should also be avoided in the first month of life and in infants with G6PD deficiency.
Amoxicillin and cephalosporins are also commonly prescribed for UTIs during breastfeeding, depending on which bacteria are causing the infection. Your provider can choose an antibiotic based on your urine culture results and your baby’s age and health status.